(24.) Spahn DR (1999) Blood substitutes artificial oxygen carriers:
perfluorocarbon emulsions.
Tservakis et al., "
Perfluorocarbon liquids in vitreoretinal surgery: a review of applications and toxicity," Cutaneous and Ocular Toxicology, vol.
Error Analysis Techniques for
Perfluorocarbon Tracer Derived Multizone Ventilation Rates.
Andrade, "Endobronchial
perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion," Journal of Surgical Research, vol.
A modified technique for extracting a dislocated lens with
perfluorocarbon liquids and viscoelastics.
Since then various filling gas such as nitrogen,
perfluorocarbons, and sulfur hexafluoride has been used as microbubble which carried a particle size of 1-5 microns.
Intratracheal
perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas exchange.
Department of Energy's National Energy Technology Laboratory used colorless, nontoxic liquids called
perfluorocarbon tracers to essentially fingerprint carbon dioxide that was injected into a coal seam in northwestern New Mexico.
There were several attempts to create alternative blood substitutes based on
perfluorocarbon emulsions in order to avoid the intoxication by hemoglobin-containing blood substitutes (Geyer, 1973; Naito and Yokoyama, 1975; Riess, 1991; Shumakov et al., 1993).
The method involves the addition of
perfluorocarbon tracers (PFTs) to the injected C[O.sub.2] stream in a predetermined proportion depending on the injection rate at the injection wellhead with a small pump that is capable of matching the well's injection pressure.
(Durham, NC) has submitted a patent application for a new invention that uses Oxycyte
perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes.
The topics of their seven papers include the interaction of drug transporters with excipients, formulation issues around lipid-based oral and parenteral delivery systems, the biological implications of lipid-based parenteral delivery systems, principles in the development of intravenous lipid emulsions, the key factor of protein absorption patterns in determining the in vivo fate of parenteral lipid formulations; nanoparticple targeting for drug delivery across the blood-brain barrier, and lipid-coated
perfluorocarbon structures as parenteral therapeutic agents.
